Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Nov 10 - Nov 15
A treatment that's still outside normal approval channels has a very different one
Newer insulin analogues may also decrease the risk of hypoglycemia
Key Takeaways Starting dose: 2 mg once weekly for 4 weeks Titration pace: Increase every 4 weeks: 2 4 8 12 mg Maximum dose: 12 mg weekly (Phase 2/3 clinical trial protocol) Total ramp-up: ~16 weeks to reach maximum dose Mechanism: Triple agonist (GLP-1 + GIP + Glucagon), the only triple-agonist in late-stage trials Weight loss: Up to 24.2% at 48 weeks (Phase 2) and 28.7% at 68 weeks (Phase 3 TRIUMPH-4) GLP-3 Retatrutide Dosage Chart Free printable reference chart showing the retatrutide (GLP-3) clinical trial titration schedule from 2 mg to 12 mg weekly
George Methodist Church
US$ 28.99
US$ 26.32
US$ 27.11
US$ 25.49
US$ 25.27
